Genedrive shares fall as CEO leaves after 11 months
Shares of Manchester-based pharmacogenetic testing compan Genedrive plc fell as much as 10% after it announced that CEO James Cheek has left the company “with immediate…
Shares of Manchester-based pharmacogenetic testing compan Genedrive plc fell as much as 10% after it announced that CEO James Cheek has left the company “with immediate…
Manchester-based Genedrive plc said UK medical authorities have recommended its genetic test for stroke sufferers before they use anti-blood clotting drugs, which should increase sales…
Shares of Manchester-based Genedrive rose as much as 7% after it announced it entered into a clinical trial agreement with a “leading multi-state physician organisation” in…
Shares of Manchester-based Genedrive, a “point of care pharmacogenetic testing company,” rose as much as 50% after it announced news from the UK’s National Institute for…
Manchester-based molecular diagnostics company Genedrive announced the immediate appointment of James Cheek as CEO. Cheek will succeed David Budd who has notified the company of his…
Shares of Manchester-based molecular diagnostics company Genedrive rose about 10% after it announced the UK’s National Institute for Health and Care Excellence (NICE) has recommended in draft guidance…
Shares of Manchester-based molecular diagnostics company Genedrive rose as much as 20% on Thursday after it said the UK’s National Institute for Health and Care Excellence (NICE) has…
Shares of Manchester-based molecular diagnostics company Genedrive fell about 20% on Monday after the firm reported a substantially widened pretax loss as revenue slumped due to a lack…
Shares of Manchester-based molecular diagnostics company Genedrive rose about 30% after it announced it has commenced engagement with the US Food and Drug Administration (FDA) “to progress…
Shares of Manchester-based molecular diagnostics company Genedrive rose about 5% on Monday after the UK Medicines and Healthcare Products Regulatory Agency granted the firm a Coronavirus Test…
Shares of Manchester-based molecular diagnostics company Genedrive rose as much as 20% on Wednesday after it announced that “expanded product validation requirements have now been completed ”…
Shares of Manchester-based molecular diagnostics company Genedrive rose about 7% on Monday after it announced it has been successful with its tender into Public Health England (PHE)…
Shares of Manchester-based molecular diagnostics company Genedrive soared more than 280% on Wednesday after it issued a trading update saying it has “refocussed a significant part…
York-based life sciences firm Aptamer Group plc announced that Arron Tolley has left his position as chief executive officer and board director with immediate effect….